---
title: Treatment of MDR Gram-negative bacilli
date:
  created: 2025-03-06T15:25:16
  updated: 2025-03-06T15:40:49
  finished: 2025-03-06T15:37:26
tags: share
share: true
categories:
  - medicine
  - abx
alias: mdr-gnb
status: finished
---
# Treatment of MDR Gram-negative bacilli  
  
![f3b5d87da5acf2c8d79ff55edb954115_MD5.jpeg](../assets/f3b5d87da5acf2c8d79ff55edb954115_MD5.jpeg)  
> Green, susceptibility anticipated to be >80%; yellow, susceptibility anticipated to be 30% to 80%; red, intrinsic resistance or susceptibility anticipated to be <30%. 1, US Food and Drug Administration–approved agent; 2, synthetic tetracycline derivative; 3, imipenem-cilastatin–relebactam; 4, synthetic aminoglycoside; 5, polymyxin class. Abbreviations: KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-β-lactamase. (Tamma et al., 2024)  
  
<!-- more -->  
  
## ESBL  
- ==Carbapenem==  
- Fluoroquinolone (UTI)  
- TMP-SMX (UTI)  
- Aminoglycoside (UTI)  
- Fosfomycin (uncomplicated cystitis, E. coli only)  
- Pip/tazo (uncomplicated cystitis, clinically improving)  
- Cefepime (uncomplicated cystitis, clinically improving)  
  
## AmpC β-lactamase  
- ==Cefepime==  
- TMP-SMX (UTI)  
- Fluoroquinolone (UTI)  
- Single-dose aminoglycoside (uncomplicated cystitis)  
- Ceftriaxone (uncomplicated cystitis)  
  
## CRE  
### R to ertapenem only  
- Extended-infusion meropenem or imipenem/cilastatin  
### UTI  
- TMP-SMX  
- Fluoroquinolone  
- Aminoglycoside  
- ==Cefiderocol==  
- ==Ceftazidime-avibactam==  
- Imipenem-cilastatin-relebactam  
- Meropenem-vaborbactam  
- Colistin (uncomplicated cystitis)   
- Fosfomycin (uncomplicated cystitis, E. coli only)  
### KPC  
- ==Ceftazidime/avibactam==  
- Imipenem-cilastatin-relebactam  
- Meropenem-vaborbactam  
- Cefiderocol  
- Minocycline (non-UTI or BSI)  
- Tigecycline (non-UTI or BSI)  
### OXA-48  
- ==Ceftazidime/avibactam==  
- Cefiderocol  
### NDM  
- ==Cefiderocol==  
- Ceftazidime/avibactam + aztreonam  
  
## CRPA  
- Extended-infusion non-carbapenem β-lactam (if S)  
- ==Ceftazidime/avibactam==  
- ==Cefiderocol==  
- Ceftolozane-tazobactam  
- Imipenem-cilastatin-relebactam  
- Aminoglycoside (UTI)  
- Colistin (uncomplicated cystitis)  
  
## CRAB  
- ==Colistin + (sulbactam or fosfomycin)==  
- High-dose minocycline (200mg Q12H)  
- High-dose tigecycline (100mg Q12H)  
- Cefiderocol（上述治療無效或沒其他藥可用時）  
- Sulbactam-durlobactam + (meropenem or imipenem/cilastatin)  
  
## *S. maltophila*  
- TMP-SMX (10–15 mg/kg TMP)  
- Levofloxacin (750mg QD)  
- High-dose minocycline (200mg Q12H)  
- Cefiderocol  
  
## Reference  
  
Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J. & Bonomo, R.A. (2024) Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. _Clinical Infectious Diseases_. ciae403. doi:[10.1093/cid/ciae403](https://doi.org/10.1093/cid/ciae403).  
  
   
```meta-bind-button  
label: "Upload"  
style: default  
id: "upload"  
actions:  
  - type: updateMetadata  
    bindTarget: date.updated  
    evaluate: true  
    value: moment().format("YYYY-MM-DDTHH:mm:ss")  
  - type: command  
    command: obsidian-mkdocs-publisher:share-one  
```